159 related articles for article (PubMed ID: 11525288)
1. Prostate pathology: histologic and molecular perspectives.
Putzi MJ; De Marzo AM
Hematol Oncol Clin North Am; 2001 Jun; 15(3):407-21. PubMed ID: 11525288
[TBL] [Abstract][Full Text] [Related]
2. Re: Inflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer?
Billis A
Int Braz J Urol; 2007; 33(4):566-8. PubMed ID: 17767768
[No Abstract] [Full Text] [Related]
3. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?
Naya Y; Ayala AG; Tamboli P; Babaian RJ
Urology; 2004 Mar; 63(3):503-8. PubMed ID: 15028446
[TBL] [Abstract][Full Text] [Related]
4. Histomorphological study of prostatic adenocarcinoma and its mimics.
Mahapatra QS; Mohanty P; Nanda A; Mohanty L
Indian J Pathol Microbiol; 2019; 62(2):251-260. PubMed ID: 30971549
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic characterisation of prostate diseases in Port Harcourt.
Obiorah CC; Nwosu SO
Niger Postgrad Med J; 2009 Jun; 16(2):158-61. PubMed ID: 19606198
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA
Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
Coogan CL; Bostwick DG; Bloom KJ; Gould VE
Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
[TBL] [Abstract][Full Text] [Related]
8. [Multi-core prostatic biopsy].
Rodríguez Duarte C
Arch Esp Urol; 2002 Oct; 55(8):907-14. PubMed ID: 12455281
[TBL] [Abstract][Full Text] [Related]
9. [Conceptual and technical issues in pathologic diagnosis of prostate cancer].
Jiang ZM; Zhang HZ; Zheng L
Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):433-5. PubMed ID: 19781187
[No Abstract] [Full Text] [Related]
10. Inflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer?
Billis A; Freitas LL; Magna LA; Ferreira U
Int Braz J Urol; 2007; 33(3):355-60; discussion 361-3. PubMed ID: 17626652
[TBL] [Abstract][Full Text] [Related]
11. [Prostatic intraepithelial neoplasia].
Molinié V
Ann Pathol; 2001 Jun; 21(3):245-54. PubMed ID: 11468562
[TBL] [Abstract][Full Text] [Related]
12. [Benign mimickers of the prostate cancer. Diagnostic challenges].
Compérat E; Varinot J; Srigley JR
Ann Pathol; 2013 Aug; 33(4):237-46. PubMed ID: 23954116
[TBL] [Abstract][Full Text] [Related]
13. A histopathological study of carcinoma of the prostate in Port Harcourt, Nigeria.
Obiorah CC; Nwosu SO
Niger J Clin Pract; 2011; 14(3):363-7. PubMed ID: 22037086
[TBL] [Abstract][Full Text] [Related]
14. Atypical cribriform lesions on prostate biopsy.
Kronz JD; Shaikh AA; Epstein JI
Am J Surg Pathol; 2001 Feb; 25(2):147-55. PubMed ID: 11176063
[TBL] [Abstract][Full Text] [Related]
15. [Detection of telomerase activity in prostate needle-biopsy samples].
Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
[TBL] [Abstract][Full Text] [Related]
16. Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy.
Langer JE; Rovner ES; Coleman BG; Yin D; Arger PH; Malkowicz SB; Nisenbaum HL; Rowling SE; Tomaszewski JE; Wein AJ; Jacobs JE
J Urol; 1996 Jan; 155(1):228-31. PubMed ID: 7490841
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
He H; Magi-Galluzzi C; Li J; Carver P; Falzarano S; Smith K; Rubin MA; Zhou M
Am J Surg Pathol; 2011 Apr; 35(4):608-14. PubMed ID: 21383613
[TBL] [Abstract][Full Text] [Related]
18. Widespread high grade prostatic intraepithelial neoplasia on biopsy predicts the risk of prostate cancer: a 12 months analysis after three consecutive prostate biopsies.
De Nunzio C; Albisinni S; Cicione A; Gacci M; Leonardo C; Esperto F; Tubaro A
Arch Ital Urol Androl; 2013 Jun; 85(2):59-64. PubMed ID: 23820650
[TBL] [Abstract][Full Text] [Related]
19. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
Goel T; Garg S
Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
